Results
1 -
6 of
6
(Click
here to explore results)
- M1 muscarinic cetylcholine receptor allosteric modulators as potential therapeutic opportunities for treating Alzheimer's disease. Michael Decker, Ulrike Holzgrabe
, Med. Chem. Commun.
, 2012
, 3
, 752
- Schizophrenia: synthetic strategies and recent advances in drug design. Maria Azmanova, Anaïs Pitto-Barry, Nicolas P. E. Barry
, Med. Chem. Commun.
, 2018
, 9
, 759
- Electroanalytical characterization of clozapine at the electrified liquid–liquid interface and its detection in soft and hard drinks. Thangaraj S. T. Balamurugan, Paweł Stelmaszczyk, Renata Wietecha-Posłuszny, Lukasz Poltorak
, Analyst
, 2024
, 149
, 2073
- Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders. Gregory J. Digby, Jana K. Shirey, P. Jeffrey Conn
, Mol. BioSyst.
, 2010
, 6
, 1345
- Current trends on microextraction by packed sorbent – fundamentals, application fields, innovative improvements and future applications. Jorge A. M. Pereira, João Gonçalves, Priscilla Porto-Figueira, José A. Figueira, Vera Alves, Rosa Perestrelo, Sonia Medina, José S. Câmara
, Analyst
, 2019
, 144
, 5048
- Current developments in LC-MS for pharmaceutical analysis. Marco Beccaria, Deirdre Cabooter
, Analyst
, 2020
, 145
, 1129